US Patent 8013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof
Patent 8013144 was granted and assigned to Chang Gung University on September, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+338 characters)
Article
Patent abstract
The present invention discloses an hnRNP K expression-inhibiting compound and a siRNA sequence thereof, wherein a siRNA sequence partially or completely complementary to the sequence of hnRNP K is used to inhibit hnRNP K expression, whereby is effectively reduced the survival rate of cancer cells in an anoxic environment.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Lih-Chyang Chen0
Yu-Sun Chang0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof US Patent 8013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof
Infobox
Patent Number
08013144
Patent Number
8013144
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08013144
Date of patent
September 6, 2011
Patent application number
12484823
Date Filed
June 15, 2009
Patent primary examiner
Find more entities like US Patent 8013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
